Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus
Condition(s):Macular Edema Following Cataract SurgeryLast Updated:May 9, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):Macular Edema Following Cataract SurgeryLast Updated:May 9, 2018Withdrawn
Condition(s):Wilson DiseaseLast Updated:April 15, 2020Completed
Condition(s):Diabetic RetinopathyLast Updated:May 3, 2013Terminated
Condition(s):Ovarian Neoplasms Malignant (Excl Germ Cell); Peritoneal Carcinoma; Fallopian Tube CancerLast Updated:November 10, 2020Completed
Condition(s):Trientine Treatment for Wilson’s DiseaseLast Updated:August 18, 2020Completed
Condition(s):Wilson’s DiseaseLast Updated:September 19, 2014Completed
Condition(s):Hypertrophic CardiomyopathyLast Updated:November 29, 2023Active, not recruiting
Condition(s):Advanced CancersLast Updated:November 18, 2015Completed
Condition(s):MelanomaLast Updated:January 30, 2019Withdrawn
Condition(s):Wilson DiseaseLast Updated:August 23, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.